Although our findings reveal the values of ARRSM for prognosis evaluation of PAAD patients and verified clinical significance and angiogenetic relevance of CASC8, AC015660.1, Z97832.2 and PAN3-AS1 in cell lines and clinical specimens, some limitations are still needed to be further improved in subsequent study. This evidence concerns the gene CASC8 and pancreatic adenocarcinoma.